Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT04598269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT04598269
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aclaris Therapeutics, Inc.
- Industry
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- ATI-1777 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2020
- Primary completion
- Apr 7, 2021
- Completion
- Apr 21, 2021
- Last update posted
- Sep 27, 2023
2020 – 2021
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Investigational Site | Scottsdale | Arizona | 85260 | — |
| Aclaris Investigational Site | Encino | California | 91436 | — |
| Aclaris Investigational Site | Los Angeles | California | 90045 | — |
| Aclaris Investigational Site | Tampa | Florida | 33613 | — |
| Aclaris Investigational Site | Indianapolis | Indiana | 46250 | — |
| Aclaris Investigational Site | Overland Park | Kansas | 66215 | — |
| Aclaris Investigational Site | Omaha | Nebraska | 68144 | — |
| Aclaris Investigational Site | Kew Gardens | New York | 11415 | — |
| Aclaris Investigational Site | Newtown Square | Pennsylvania | 19073 | — |
| Aclaris Investigational Site | Fountain Inn | South Carolina | 29644 | — |
| Aclaris Investigational Site | Austin | Texas | 78759 | — |
| Aclaris Investigational Site | San Antonio | Texas | 78213 | — |
| Aclaris Investigational Site | Lynchburg | Virginia | 24501 | — |
| Aclaris Investigational Site | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04598269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2023 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04598269 live on ClinicalTrials.gov.